Research & Development: Page 55

PharmaVoice Team/PharmaVoice

The Year of the Extreme Makeover

Every sector in the industry is in a state of flux. In this special issue of PharmaVOICE, more than 160 thought leaders throughout the life-sciences industry discuss the changing market dynamics. According to PricewaterhouseCooper’s 14th Annual Global CEO Survey, which looks at the concerns expre...
By Denise Myshko and Robin Robinsons • Nov. 11, 2011
PharmaVoice Team/PharmaVoice

Talent Pool

Pharmaceutical POOL Percival BARRETTO-KO Astellas Realigns Executive Team Astellas US, the U.S. affiliate of Tokyo-based Astellas Pharma, has named Percival Barretto-Ko senior VP, corporate strategy and government affairs. Mr. Barretto-Ko was previously executive director, corporate strategy and ...
By PharmaVoice Team • Nov. 11, 2011
Explore the Trendline➔

Stock via Getty Images

Trendline

Clinical trial diversity

As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff
PharmaVoice Team/PharmaVoice

PharmaTrax

Sales, marketing, And R&D?Trends affecting the healthcare industry Healthcare Reform Viewed as Mixed Blessing Trend: Consumers believe the success of healthcare reform is dependent on achieving cost reduction and quality improvement — two things that traditionally stand in opposition to each...
By Carolyn Gretton • Nov. 11, 2011
PharmaVoice Team/PharmaVoice

On the Calendar

Industry Events and Conferences, including SPECIAL DISCOUNTS Coming ATTRACTIONS Attendees interested in maximizing their clinical trial performance by bridging the gap between identifying and implementing metrics, learning about best practices on processing data and on-site performance to improve...
By PharmaVoice Team • Nov. 11, 2011
PharmaVoice Team/PharmaVoice

Connecting with Professional and Patient Targets: Going Back to the Future with Live Telephone Interviewing

More than a decade ago, the Internet took the market research world by storm. Online studies offer a fast, simple, cost-effective way to reach target audiences. A wide range of factors, however, often makes healthcare projects difficult to complete using online alone: Gatekeepers — such as office...
By Chris De Angelis • Sept. 27, 2011
PharmaVoice Team/PharmaVoice

Hello South Africa

A Diverse and Sophisticated Market With a diverse population, a thriving research environment, strong infrastructure along with geographic reach into the rest of Africa, South Africa has many advantages for the global pharma industry. With its population of more than 50 million people from divers...
By Kim Ribbink • Sept. 27, 2011
PharmaVoice Team/PharmaVoice

New Science Means New Ways to Target Disease

Epigenetics — the study of changes in gene expression — is rapidly emerging as a field that presents tremendous opportunity for drug discovery. We are on the edge of a new biology. It turns out that our genes are just part of the story about what makes us who we are. Much has been learned over ...
By Denise Myshko • Sept. 27, 2011
PharmaVoice Team/PharmaVoice

30 Years of AIDS Research

Antiretroviral agents have revolutionized treatment for HIV/AIDS. But there is still a tremendous need for prevention and less-costly therapies. Much progress has been made over the last 30 years in the HIV/AIDS arena. HIV infection is no longer considered a death sentence, thanks to antitretrov...
By Denise Myshko • Sept. 27, 2011
PharmaVoice Team/PharmaVoice

A Changing Market Environment Requires New PLM Strategies

In a market environment that is increasingly value-based, the industry must begin to review its product life-cycle management (PLM) strategy and prepare for more effective ways to cope with the evolving challenges when it comes to pipeline maintenance. For example, companies need to start impleme...
By Robin Robinson • Sept. 27, 2011
PharmaVoice Team/PharmaVoice

Last Word

Taking Innovation to a New Level Ulrich Betz, Ph.D., Director at Merck Serono Portfolio Development and Head of the Department Center of Innovation, talks about fostering innovation and entrepreneurial thinking within the company. PV: What is the Merck Serono internal Innospire innovation program...
By Ulrich Betz • Sept. 27, 2011
PharmaVoice Team/PharmaVoice

Pharma Trax

Sales, marketing, And R&D?Trends affecting the healthcare industry Vision and Planning are Key to Efficient Real-World Data Use Trend: Market forces are driving the need for real-world data in the life-sciences industry. Recommendations for Real-World Data Research » Develop a shared vision...
By PharmaVoice Team • Sept. 27, 2011
PharmaVoice Team/PharmaVoice

Tools of the Trade

New electronic and web-based applications, sites, and technologies POR Provides Real-Time Engagement Between Doctors and Brands Trend: Driven by physician access issues and shrinking sales forces, pharma brand marketers are looking for ways to use nonpersonal and digital promotion more effectivel...
By PharmaVoice Team • Sept. 27, 2011
PharmaVoice Team/PharmaVoice

What's New

New healthcare-related products, services, and companies Lumina Seeks to Support Medical Affairs Teams Trend: Pharma and biotech medical affairs organizations are playing an increasingly critical role in addressing the information needs of healthcare professionals and patients. KnowledgePoint360 ...
By PharmaVoice Team • Sept. 27, 2011
PharmaVoice Team/PharmaVoice

Outlet

Opinions, insights, and commentary from around the industry Getting to Variable Costs: Regulated Cloud-Sourcing Emerges Chuck Saldarini, CEO of Sentrx Safety Solutions, is redefining the standard for safety services by putting best practices into action, developing innovative solutions founded o...
By Chuck Saldarini • Sept. 27, 2011
PharmaVoice Team/PharmaVoice

The Impact of an Integrated Execution Environment on Data Management in Adaptive Clinical Trials

Contributed By Corey B. Dunham, VP Data Management and Statistics, North America Anyone who has baked a cake can tell you that the quality of the ingredients is equally as important as following the recipe. Data quality in clinical trials is much the same way. You can follow the protocol and stan...
By Corey B. Dunham • Aug. 29, 2011
PharmaVoice Team/PharmaVoice

Decoding Data Dynamics

By Carolyn Gretton The shift in life-sciences development toward more personalized therapeutics is driving a need for proactive clinical data management (CDM) strategies that take into account the volume and complexity of information emerging from today’s clinical trials. Data management is being...
By Carolyn Gretton • Aug. 29, 2011
PharmaVoice Team/PharmaVoice

Hola Mexico: Pharma Drawn to U.S. Neighbor

By Kim Ribbin Growing health coverage, high medical standards, a motivated patient population, and huge geographic advantages make Mexico an appealing market for the pharmaceutical industry. With a population of around 110 million people and a growing focus on healthcare, Mexico has fast becom...
By Kim Ribbink • Aug. 29, 2011
PharmaVoice Team/PharmaVoice

Beyond Stem Cells

By Denise Myshko It may seem like science fiction: a trachea grown from stem cells and implanted into a human being. But it’s not; this is an actual account of the power of stem cells and regenerative medicine. The 36-year-old patient, who had been suffering from late-stage tracheal cancer, recei...
By Denise Myshko • Aug. 29, 2011
PharmaVoice Team/PharmaVoice

Mentoring: More Crucial Than Ever

By Robin Robinson With the industry in constant flux, industry leaders say mentoring is key for career advancement. Declining budgets, the emergence of small innovative startups with fewer resources, busy schedules, and an ever-changing work environment are a few of the factors that make mentorin...
By Robin Robinson • Aug. 29, 2011
PharmaVoice Team/PharmaVoice

The New Frontier: Therapeutic Vaccines

By Denise Myshko Researchers continue to evaluate the sustainability of powering the immune system to treat cancers and other serious diseases. For years researchers have been trying to find a way to trigger the body’s immune system to recognize cancers and other diseases. Early attempts to use c...
By Denise Myshko • Aug. 29, 2011
PharmaVoice Team/PharmaVoice

Public Service: Improving Adherence

By Robin Robinson For the next three years, the National Consumer League and its 100 partners will focus on improving adherence for chronic diseases. With almost 75% of patients in the United States not taking medicine as prescribed by their doctors, the public awareness campaign, Script Your Fut...
By Robin Robinson • Aug. 29, 2011
PharmaVoice Team/PharmaVoice

PharmaTrax

Sales, marketing, And R&D Trends affecting the healthcare industry By Carolyn Gretton U.S. Prescription Drug Spending Posts Modest Increase for 2010 Trend: Fewer physician office visits and new therapy starts indicate that U.S. patients are scaling back their use of prescription medicines ami...
By Carolyn Gretton • Aug. 29, 2011
PharmaVoice Team/PharmaVoice

UpFront

UpFront Awards… » CSL Behring Receives NORD Award CSL Behring has received the National Organization for Rare Disorders (NORD) 2011 Corporate Award for new treatments brought to market for patients with rare diseases. CSL Behring’s new treatment, Factor XIII concentrate (human), is approved fo...
By PharmaVoice Team • Aug. 29, 2011
PharmaVoice Team/PharmaVoice

Letter from the Editor

The New Market Frontier New segmentation techniques might just be the way to uncover the next growth opportunity for brands. Audience segmentation has been around forever and is used by most companies to identify those consumers who are the right fit for their brands — and companies are spending ...
By Taren Grom • Aug. 29, 2011
PharmaVoice Team/PharmaVoice

2011 PharmaVOICE 100 - Who's on the List by Section

The Commanders & Chiefs Frank Baldino Jr., Ph.D. Cephalon Inc. Donna Beardsworth. Beardsworth Group Calep A. (Joe) Boyd III MCS Healthcare Public Relations Randall Carpenter, M.D. Seaside Therapeutics N. Anthony Coles, M.D. Onyx Pharmaceuticals B. Reid Connolly evoke interaction Donna Cryer C...
By PharmaVoice Team • July 26, 2011